Kura Oncology (KURA) Change in Account Payables (2010 - 2026)
Kura Oncology (KURA) reported Change in Account Payables of $2.0 million for Q1 2026, down 35.5% year-over-year from $3.1 million in Q1 2025, and down 35.5% on a QoQ basis from $3.1 million in Q1 2025.
Kura Oncology (KURA) has 8 years of Change in Account Payables data on file, last reported at $2.0 million in Q1 2026.
- Quarterly Change in Account Payables fell 35.5% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.1 million (up 49.81% YoY) and the FY2025 annual result came in at $4.5 million, up 376.52% from the prior year.
- Change in Account Payables slipped to $2.0 million in Q1 2026 per KURA's latest filing, from $3.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.1 million in Q1 2025 and bottomed at $2.0 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 2.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.03 Mn |
| Mar 31, 2026 | 2.03 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Mar 31, 2015 | 927,000.00 |
| Mar 31, 2015 | 927,000.00 |
| Dec 31, 2014 | -8,280.00 |
| Dec 31, 2014 | -8,280.00 |
| Sep 30, 2014 | 2,527.00 |
| Sep 30, 2014 | 2,527.00 |
| Jun 30, 2014 | 7,442.00 |
| Jun 30, 2014 | 7,442.00 |
| Mar 31, 2014 | 363.00 |
| Mar 31, 2014 | 363.00 |
| Dec 31, 2013 | -300.00 |
| Dec 31, 2013 | -300.00 |
| Sep 30, 2013 | 475.00 |
| Sep 30, 2013 | 475.00 |
| Jun 30, 2013 | -6,115.00 |
| Jun 30, 2013 | -6,115.00 |
| Mar 31, 2013 | 4,440.00 |
| Mar 31, 2013 | 4,440.00 |
| Dec 31, 2012 | 1,217.00 |
| Dec 31, 2012 | 1,217.00 |
| Sep 30, 2012 | 458.00 |
| Sep 30, 2012 | 458.00 |
| Jun 30, 2012 | -3,641.00 |
| Jun 30, 2012 | -3,641.00 |
| Mar 31, 2012 | 889.00 |
| Mar 31, 2012 | 889.00 |
| Dec 31, 2011 | 329.00 |
| Dec 31, 2011 | 329.00 |
| Sep 30, 2011 | 297.00 |
| Sep 30, 2011 | 297.00 |
| Jun 30, 2011 | -1,004.00 |
| Jun 30, 2011 | -1,004.00 |
| Mar 31, 2011 | 1,140.00 |
| Mar 31, 2011 | 1,140.00 |
| Dec 31, 2010 | 1,534.00 |
| Dec 31, 2010 | 1,534.00 |
| Sep 30, 2010 | 356.00 |
| Sep 30, 2010 | 356.00 |